Literature DB >> 7545185

Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen.

L Millon1, T Barale, M C Julliot, J Martinez, G Mantion.   

Abstract

The glucuronoxylomannan component of the Cryptococcus neoformans capsular polysaccharide confers serotype specificity, and its detection in cerebrospinal fluid or serum by the latex agglutination test is used for diagnosis. Low-molecular-weight hydroxyethyl starches can be used as an alternative to albumin for vascular filling. This study reports the occurrence of a false-positive result with the Pastorex Cryptococcus test (Sanofi Diagnostics Pasteur, Marnes la Coquette, France) for a patient receiving hydroxyethyl starch characterized by a substitution ratio of 0.6 (Elohes, Biosedra, Sèvres, France).

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7545185      PMCID： PMC228299          DOI： 10.1128/jcm.33.7.1917-1919.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Septicemia due to DF-2. Cause of a false-positive cryptococcal latex agglutination result.

Authors:  M A Westerink; D Amsterdam; R J Petell; M N Stram; M A Apicella
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

2.  Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen.

Authors:  L D Gray; G D Roberts
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Control for rheumatoid factor in the latex test for cryptococcosis.

Authors:  J E Bennett; J W Bailey
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

4.  [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].

Authors:  H Köhler; H Zschiedrich; A Linfante; F Appel; H Pitz; R Clasen
Journal:  Klin Wochenschr       Date:  1982-03

5.  False positive latex tests for cryptococcal antigen in cerebrospinal fluid.

Authors:  R J Hay; D W Mackenzie
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

6.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

7.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.

Authors:  R Ikeda; T Shinoda; Y Fukazawa; L Kaufman
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

9.  Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.

Authors:  R Cherniak; R G Jones; E Reiss
Journal:  Carbohydr Res       Date:  1988-01-15       Impact factor: 2.104

10.  Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection.

Authors:  E J McManus; J M Jones
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948
View more
  2 in total

1.  False-positive cryptococcal antigen test associated with use of BBL Port-a-Cul transport vials.

Authors:  Deborah A Wilson; Mary Sholtis; Sharon Parshall; Gerri S Hall; Gary W Procop
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

2.  Comparison of Antigen Detection and Nested PCR in CSF Samples of HIV Positive and Negative Patients with Suspected Cryptococcal Meningitis in a Tertiary Care Hospital.

Authors:  Sunita Kumari; Rajesh Kumar Verma; Dharmendra Prasad Singh; Ramakant Yadav
Journal:  J Clin Diagn Res       Date:  2016-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.